Immediate Impact
17 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Dengue virus pathogenesis and host molecular machineries
2024 Standout
Works of Delia Yu being referenced
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial
2020
Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Delia Yu | 140 | 177 | 12 | 16 | 6 | 195 | |
| Luong Thi Hue Tai | 132 | 181 | 14 | 17 | 6 | 205 | |
| Emily Herrington | 203 | 238 | 27 | 12 | 9 | 284 | |
| Thelma Laot | 143 | 160 | 30 | 19 | 9 | 211 | |
| Priya Shastri | 158 | 171 | 20 | 8 | 8 | 205 | |
| Elina Erra | 227 | 262 | 21 | 10 | 9 | 280 | |
| Paresh S. Shah | 214 | 266 | 17 | 16 | 10 | 291 | |
| Cao Thi Tam | 202 | 239 | 21 | 11 | 5 | 292 | |
| William L. Pond | 216 | 238 | 38 | 10 | 14 | 287 | |
| Valéria Christina de Rezende Féres | 225 | 282 | 17 | 5 | 15 | 298 | |
| Renato Antônio dos Santos Oliveira | 160 | 199 | 29 | 10 | 11 | 256 |
All Works
Loading papers...